Kogo, Takahiro
Muraoka, Yuki
Nishigori, Naomi
Akiyama, Yuki
Hama, Yuki
Tsujikawa, Akitaka
Article History
Received: 17 October 2025
Accepted: 18 December 2025
First Online: 20 December 2025
Declarations
:
: None of the authors have proprietary interests in any product described in this article. None of the authors have any conflicts of interest or proprietary interests in any product described in this article. The authors report the following relationships: T. Kogo: Canon; Y. Muraoka: Alcon Japan, Novartis Pharma, Bayer Yakuhin, Senju Pharmaceutical, Canon, Santen Pharmaceutical, AMO Japan, HOYA, Johnson & Johnson K.K.; N. Nishigori: None; Y. Akiyama: None; Y. Hama; None: A. Tsujikawa: Canon, Findex, Santen Pharmaceutical, Sumitomo Pharma, Astellas, Otsuka Pharmaceutical, Senju Pharmaceutical, Alcon Japan, Wakamoto Pharmaceutical, Chugai Pharmaceutical, HOYA, ROHTO NITTEN, Novartis Pharma, Bayer Yakuhin, AMO Japan, Kowa Company, MSD, Kowa Pharmaceutical, Johnson & Johnson K.K., ROHTO Pharmaceutical, Boehringer Ingelheim, Janssen Pharmaceutical, KYOWA KIRIN.